Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

PARENTERAL FORMULATION IS FOR HOSPITAL PRESCRIBING ONLY
BRAND PRESCRIBING IS REQUIRED

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

NHS England guidance for CCGs on prescribing of OTC products (Mar-18):

• Prescriptions for treatment of mild to moderate hay fever should not be routinely offered - appropriate for self-care using OTC treatments

General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Amber with no shared care. High dose steriod inhaler. Must be initiated by a specialist. 

Ensure that the device for salbutamol inhaler is specified on the prescription in line with the LPP RighCare Gulletin October 2017: Advice on Prescribing Inhalers by Brand Name & Device 

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

Inhalers should be prescribed by brand and device

• There are a number of new inhaler devices and the drugs they contain in the UK respiratory market
• Generic prescribing for an inhaler can result in the patient getting different devices on different occasions.

NHS England guidance for CCGs on prescribing of OTC products (Mar-18):

• Prescriptions for treatment of mild to moderate hay fever should not be routinely offered - appropriate for self-care using OTC treatments

Link to 1-page patient information sheet to support discussions between patients and healthcare professionals. 

General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list.

NHS England guidance for CCGs on prescribing of OTC products (Mar-18):

• Prescriptions for treatment of mild to moderate hay fever should not be routinely offered - appropriate for self-care using OTC treatments

Link to 1-page patient information sheet to support discussions between patients and healthcare professionals. 

General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list.

Unless a shared care policy is available, this medicines is for Hospital Only Prescribing. If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records.

If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
 

• Barts Health Shared Care Guidelines

"Allergic rhinitis - for use in patients who remain symptomatic in moderate/severe house dust mite induced allergic rhinitis despite regular treatment with topical nasal steroids and oral antihistamines (12+ years)
Allergic asthma- for use in patients who remain uncontrolled on ICS/LABA + SABA - step 3 of GINA as an additional add on therapy (18+ years)
Only for Homerton as other centres did not express an interest"

NHS England guidance for CCGs on prescribing of OTC products (Mar-18):

• Prescriptions for treatment of mild to moderate hay fever should not be routinely offered - appropriate for self-care using OTC treatments

Link to 1-page patient information sheet to support discussions between patients and healthcare professionals. 

General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list.

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records.

Click here for the Shared Care Guideline Repository


If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
 

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records.

Click here for the Shared Care Guideline Repository


If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .